Drug profile · INN
lucinactant
SURFAXIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lucinactant (SURFAXIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.
Key facts
INN lucinactant
Brand SURFAXIN
Route INTRATRACHEAL
Formulation SUSPENSION
Frequently asked questions
What is lucinactant?
lucinactant (SURFAXIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.
What is the brand name for lucinactant?
SURFAXIN is a marketed brand name for lucinactant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lucinactant?
lucinactant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.